Literature DB >> 7953384

Pathobiology of intimal hyperplasia.

M G Davies1, P O Hagen.   

Abstract

In the current vascular interventional environment, high restenosis rates have increased awareness of the significance of intimal hyperplasia, a chronic structural lesion that develops after vessel wall injury, and which can lead to luminal stenosis and occlusion. Intimal hyperplasia may be defined as the abnormal migration and proliferation of vascular smooth muscle cells with associated deposition of extracellular connective tissue matrix. The pathology of intimal hyperplasia is reviewed with particular attention to its physiology, pharmacology, cell biology and molecular biology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7953384     DOI: 10.1002/bjs.1800810904

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  79 in total

Review 1.  Photodynamic therapy: shedding light on restenosis.

Authors:  R Mansfield; S Bown; J McEwan
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

2.  Photodynamic therapy induces apoptosis in intimal hyperplastic arteries.

Authors:  G M LaMuraglia; J Schiereck; J Heckenkamp; G Nigri; P Waterman; D Leszczynski; S Kossodo
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

3.  Rapid development of vein graft atheroma in ApoE-deficient mice.

Authors:  H Dietrich; Y Hu; Y Zou; U Huemer; B Metzler; C Li; M Mayr; Q Xu
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

4.  Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery.

Authors:  Yiping Zou; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2012-05-08       Impact factor: 2.192

Review 5.  Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.

Authors:  Daniel Radke; Wenkai Jia; Dhavan Sharma; Kemin Fena; Guifang Wang; Jeremy Goldman; Feng Zhao
Journal:  Adv Healthc Mater       Date:  2018-05-07       Impact factor: 9.933

6.  Intracoronary photodynamic therapy reduces neointimal growth without suppressing re-endothelialisation in a porcine model.

Authors:  R Waksman; I M Leitch; J Roessler; H Yazdi; R Seabron; F Tio; R W Scott; R I Grove; S Rychnovsky; B Robinson; R Pakala; E Cheneau
Journal:  Heart       Date:  2006-01-06       Impact factor: 5.994

7.  Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury.

Authors:  Miao Wang; Kaori Ihida-Stansbury; Devashish Kothapalli; Mathieu C Tamby; Zhou Yu; Lihong Chen; Gregory Grant; Yan Cheng; John A Lawson; Richard K Assoian; Peter L Jones; Garret A Fitzgerald
Journal:  Circulation       Date:  2011-01-31       Impact factor: 29.690

8.  Long-term inhibition of intimal hyperplasia using vascular photodynamic therapy in balloon-injured carotid arteries.

Authors:  Takeshi Wakamatsu; Takashi Saito; Junichi Hayashi; Toshiaki Takeichi; Kiyoshi Kitamoto; Katsuo Aizawa
Journal:  Med Mol Morphol       Date:  2005-12       Impact factor: 2.309

9.  Myeloid cell 5-lipoxygenase activating protein modulates the response to vascular injury.

Authors:  Zhou Yu; Emanuela Ricciotti; Takashi Miwa; Shulin Liu; Kaori Ihida-Stansbury; Gavin Landesberg; Peter L Jones; Rosario Scalia; Wen-Chao Song; Richard K Assoian; Garret A FitzGerald
Journal:  Circ Res       Date:  2012-12-18       Impact factor: 17.367

10.  Location-dependent coronary artery diffusive and convective mass transport properties of a lipophilic drug surrogate measured using nonlinear microscopy.

Authors:  Joseph T Keyes; Bruce R Simon; Jonathan P Vande Geest
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.